Navigation Links
European Health Care Institutions Forced to Select Lower-Priced Interventional Cardiology Devices

WALTHAM, Mass., July 9 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the ongoing economic crisis is putting pressure on publicly-funded health care systems across Europe, intensifying the decline of interventional cardiology (IC) device prices in the region. MRG's European Markets for Interventional Cardiology Devices 2009 (Part II) report details the extent to which competitive pricing and discounts among IC device vendors is resulting in price erosion in Belgium, Luxembourg, the Netherlands, Norway, Denmark, Finland, Sweden, Spain, and Switzerland.

IC device vendors are engaging in price undercutting and offering high-volume discounts or bundling deals with other products in their portfolios in order to encourage sales, resulting in price erosion. The health care systems in the Netherlands and Switzerland (beginning in 2012) provide only general funding for IC procedures, despite the varying cost of devices used. In order to operate within set budgets, European health care facilities must often choose lower-cost devices. Contract tenders between sellers and group purchasing organizations will further add to price erosion. In exchange for high-volume sales of their products, manufacturers offer significant discounts. This method of business is becoming more common across Europe, particularly in the Nordic countries and Spain.

"The global economic recession has certainly intensified the extent of price erosion for IC devices across Europe," says Stephanie LaBelle, Senior Analyst at MRG. "Institutions operating within the public health care systems of these European countries are choosing lower-priced devices to meet budgetary constraints."

MRG's new report, European Markets for Interventional Cardiology Devices 2009 (Part II) provides important insight into the reasons behind and extent of the changes in IC device pricing. Additionally, the report provides full breakdowns of IC procedures by type and device unit sales by subtype, including five-year forecasts, up-to-date market shares, and in-depth qualitative insights.

About Millennium Research Group

Millennium Research Group (, a Decision Resources, Inc. company (, is the global authority on medical technology market intelligence and the leading provider of strategic information to the health care sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack(TM) projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the health care industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Amy Krohn
    Millennium Research Group
    416-364-7776 x101

    Elizabeth Marshall
    Decision Resources Inc.

SOURCE Millennium Research Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. European Consumers Share a High Interest in Healthcare, but Hold Varied Views on Many Health Issues New TNS Healthcare Study Reveals Both Differences and Similarities in Health Views across Europe
2. New impact factor of European Urology underlines journals outstanding position
3. European Prices of 170 Best-Selling Drugs Averaged 40 Percent Less Than U.S. Prices in 2008
4. Frost & Sullivan Identifies Innovative and Cost-Effective Technology as Key Competitive Factor in European Medical Device Market
5. European Medicines Agency (EMEA) Approves Cell Therapeutics, Inc.s September Meeting Request to Discuss OPAXIO(TM) Marketing Authorization Application
6. Euro RSCG Life Acquires Medicom Group to Further Strengthen Its Global and European Medical Education Offering
7. Frost & Sullivan European Gastroenterology Technology Implementation of the Year Award Bestowed on Crospon
8. Simbionix Signs Agreement With the European Association for Endoscopic Surgery
9. The European Association for the Study of the Liver renews publishing partnership with Elsevier
10. Growing Proteomics Market and the Current Economic Crisis Could Act in Tandem to Spur Growth in the European 2 Dimensional Gel Electrophoresis Market, States Frost & Sullivan
11. Prostate screening studies reviewed in European Urology July issue
Post Your Comments:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... 23, 2016  Experian Health, the healthcare ... the patient payment and care experience, today ... products and services that will enhance the ... offerings. These award-winning solutions will enable healthcare ... compliant in an ever-changing environment and redefine ...
Breaking Medicine Technology: